Glioma stem cell-derived exosomal lncRNA HOXA-AS2 promoted proliferation, migration, invasion and stemness in glioma

doi:10.19401/j.cnki.1007-3639.2022.12.010

Abstract

Abstract:

Background and purpose: Exosomes are important messengers that mediate the crosstalk between cancer cells and recipient cells in the tumor microenvironment; however, the role of extracellular exosomal long non-coding RNA (lncRNA) in the cell-cell communications of glioma stem cells (GSCs) and glioma cells remains unclear. This study investigated the effects of exosome-derived lncRNAs on proliferation, migration, invasion and stemness in glioma. Methods: The datasets containing low-grade glioma (LGG) and high-grade glioma (HGG) lncRNA expression data were downloaded from the Chinese Glioma Genome Atlas (CGGA) and the Cancer Genome Atlas (TCGA) databases. Differentially expressed lncRNA (DelncRNA) between LGG and HGG tissues was identified, and the relationship between HOXA-AS2 levels and overall survival (OS) of glioma patients was analyzed. GSCs were isolated from human glioma cell line SHG44, and CD133⁺ enriched cells were detected by flow cytometry. The expression levels of stem cell-related proteins (CD133, SOX2 and OCT4) were detected by Western blot. Exosomes derived from SHG44-GSCs were extracted and identified, and labeled with PKH26 cell membrane dye. Then SHG44-GSCs transfected with Cy3-labeled HOXA-AS2 were indirectly co-cultured with SHG44 cells. The levels of HOXA-AS2 in SHG44-GSCs and SHG44-GSC-derived exosomes were detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR). The plVX-IRES-PURO HOXA-AS2 lentivirus plasmid and lentivirus shRNA containing targeting HOXA-AS2 plasmid were used for lentivirus transfection. The effect of HOXA-AS2 derived from SHG44-GSC on the proliferation and invasion of SHG44 cells was detected by cell counting kit-8 (CCK-8) and transwell assays. Results:HOXA-AS2 was highly expressed in gliomas, and was associated with worse OS in patients (P<0.01). The proportion of CD133⁺ cells were significantly higher in SHG44-GSC than in SHG44 cells (P<0.000 1). The expression levels of stem cell related proteins (CD133, SOX2 and OCT4) in SHG44-GSC cells were significantly higher compared with parental SHG44 cells (P<0.000 1). HOXA-AS2 level was significantly increased in SHG44-GSC cells (P<0.000 1). PKH26-labeled exosomes were absorbed by SHG44 cells, and Cy3-labeled HOXA-AS2 could be observed in SHG44 cells. HOXA-AS2 levels were significantly increased in HOXA-AS2 OE transfected SHG44-GSCs cells (SHG44-GSC/HOXA-AS2 OE) and SHG44-GSC/HOXA-AS2 OE-derived exosomes (SHG44-GSC/HOXA-AS2 OE-Exo) (P<0.01). In addition, HOXA-AS2 levels were significantly increased in SHG44 cells co-cultured with SHG44-GSC/HOXA-AS2 OE cells (P<0.01). HOXA-AS2 could be transferred from SHG44-GSC to SHG44 cells through exosomes. Functionally, SHG44-GSC/HOXA-AS2 OE-Exo significantly promoted the proliferation, migration and invasion of SHG44 cells. Conclusion: Exosomal HOXA-AS2 derived from SHG44-GSCs significantly promoted glioma cell proliferation, migration, invasion and stemness, suggesting that HOXA-AS2 may be a potential therapeutic target for glioma.

Key words: Gliomas, Cancer stem-like cells, Exosomes, Long non-coding RNA, HOXA-AS2

CLC Number:

R739.41

LIAO Xinghe, LIU Zhantao, LIU Minghui. Glioma stem cell-derived exosomal lncRNA HOXA-AS2 promoted proliferation, migration, invasion and stemness in glioma[J]. China Oncology, 2022, 32(12): 1218-1228.

Figures/Tables 5

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

References 35

[1]	OSTROM Q T, BAUCHET L, DAVIS F G, et al. The epidemiology of glioma in adults: a “state of the science” review[J]. Neuro Oncol, 2014, 16(7): 896-913. doi: 10.1093/neuonc/nou087
[2]	MALTA T M, DE SOUZA C F, SABEDOT T S, et al. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications[J]. Neuro Oncol, 2018, 20(5): 608-620. doi: 10.1093/neuonc/nox183
[3]	SHI J, ZHANG Y, QIN B, et al. Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma[J]. J Exp Clin Cancer Res, 2019, 38(1): 395. doi: 10.1186/s13046-019-1390-x
[4]	MIYAUCHI J T, TSIRKA S E. Advances in immunotherapeutic research for glioma therapy[J]. J Neurol, 2018, 265(4): 741-756. doi: 10.1007/s00415-017-8695-5 pmid: 29209782
[5]	LV Q L, WANG L C, LI D C, et al. Knockdown lncRNA DLEU1 inhibits gliomas progression and promotes temozolomide chemosensitivity by regulating autophagy[J]. Front Pharmacol, 2020, 11: 560543.
[6]	FU C, LI D Y, ZHANG X N, et al. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of miR-128-3p/GREM1 axis and BMP signaling pathway[J]. Neurotherapeutics, 2018, 15(4): 1139-1157. doi: 10.1007/s13311-018-0649-9 pmid: 30120709
[7]	CHEN P Y, LI X D, MA W N, et al. Comprehensive transcriptomic analysis and experimental validation identify lncRNA HOXA-AS2/miR-184/COL6A2 as the critical ceRNA regulation involved in low-grade glioma recurrence[J]. Onco Targets Ther, 2020, 13: 4999-5016. doi: 10.2147/OTT.S245896
[8]	LIU X, ZHU Q J, GUO Y, et al. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis[J]. Biomedecine Pharmacother, 2019, 117: 109069.
[9]	AKELLA N M, LE MINH G, CIRAKU L, et al. O-GlcNAc transferase regulates cancer stem-like potential of breast cancer cells[J]. Mol Cancer Res, 2020, 18(4): 585-598. doi: 10.1158/1541-7786.MCR-19-0732 pmid: 31974291
[10]	MOHIUDDIN I S, WEI S J, KANG M H. Role of OCT4 in cancer stem-like cells and chemotherapy resistance[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(4): 165432.
[11]	SUN Z, WANG L, DONG L H, et al. Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium[J]. J Cell Mol Med, 2018, 22(8): 3719-3728. doi: 10.1111/jcmm.13676
[12]	LI W G, JIANG P F, SUN X L, et al. Suppressing H19 modulates tumorigenicity and stemness in U251 and U87MG glioma cells[J]. Cell Mol Neurobiol, 2016, 36(8): 1219-1227. pmid: 26983719
[13]	SASAKI R, KANDA T, YOKOSUKA O, et al. Exosomes and hepatocellular carcinoma: from bench to bedside[J]. Int J Mol Sci, 2019, 20(6): E1406.
[14]	KAHLERT C, KALLURI R. Exosomes in tumor microenvironment influence cancer progression and metastasis[J]. J Mol Med (Berl), 2013, 91(4): 431-437. doi: 10.1007/s00109-013-1020-6 pmid: 23519402
[15]	XIONG L, WANG F, XIE X Q. Advanced treatment in high-grade gliomas[J]. J BUON, 2019, 24(2): 424-430. pmid: 31127986
[16]	NAN Y. Molecular targeted therapy in glioblastoma[J]. J Int Oncol, 2017, 44: 689-692.
[17]	KOPP F, MENDELL J T. Functional classification and experimental dissection of long noncoding RNAs[J]. Cell, 2018, 172(3): 393-407. doi: S0092-8674(18)30048-5 pmid: 29373828
[18]	ANGELOPOULOU E, PAUDEL Y N, PIPERI C. Critical role of HOX transcript antisense intergenic RNA (HOTAIR) in gliomas[J]. J Mol Med (Berl), 2020, 98(11): 1525-1546. doi: 10.1007/s00109-020-01984-x
[19]	曲来强, 彭静, 喻磊, 等. lncRNA HOXA-AS2对视网膜母细胞瘤细胞增殖和上皮间质转化的影响[J]. 中国肿瘤临床与康复, 2021, 28(11): 1308-1311.
	QU L Q, PENG J, YU L, et al. Effects of LncRNA HOXA-AS2 on the proliferation and epithelial-mesenchymal transition of retinoblastoma cells[J]. Chin J Clin Oncol Rehabilitation, 2021, 28(11): 1308-1311.
[20]	陈升阳, 陈艳军, 胡水全, 等. LncRNA HOXA-AS2在胰腺癌组织中的表达及对细胞增殖和侵袭力的影响[J]. 实用医学杂志, 2021, 37(14): 1795-1799.
	CHEN S Y, CHEN Y J, HU S Q, et al. Expression of lncRNA HOXA-AS2 in pancreatic cancer tissues and its effect on cell proliferation and invasion[J]. J Pract Med, 2021, 37(14): 1795-1799.
[21]	ZHANG P, CAO P H, ZHU X F, et al. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma[J]. Oncotarget, 2017, 8(20): 33137-33143. doi: 10.18632/oncotarget.16561 pmid: 28388535
[22]	俞盛健, 麻怀露, 陈王洋, 等. 基于生物信息学的脑胶质瘤预后风险长链非编码RNA筛选[J]. 温州医科大学学报, 2020, 50(3): 199-205.
	YU S J, MA H L, CHEN W Y, et al. Bioinformatics study on the screening of long-chain noncoding RNA for prognostic risk of glioma[J]. J Wenzhou Med Univ, 2020, 50(3): 199-205.
[23]	WU L X, ZHU X Q, SONG Z Y, et al. Long non-coding RNA HOXA-AS2 enhances the malignant biological behaviors in glioma by epigenetically regulating RND3 expression[J]. Onco Targets Ther, 2019, 12: 9407-9419. doi: 10.2147/OTT.S225678
[24]	GAO Y N, YU H, LIU Y H, et al. Long non-coding RNA HOXA-AS2 regulates malignant glioma behaviors and vasculogenic mimicry formation via the miR-373/EGFR axis[J]. Cell Physiol Biochem, 2018, 45(1): 131-147. doi: 10.1159/000486253 pmid: 29310118
[25]	DAI J, SU Y Z, ZHONG S Y, et al. Exosomes: key players in cancer and potential therapeutic strategy[J]. Signal Transduct Target Ther, 2020, 5(1): 145.
[26]	XU J S, LIAO K L, ZHOU W M. Exosomes regulate the transformation of cancer cells in cancer stem cell homeostasis[J]. Stem Cells Int, 2018, 2018: 4837370.
[27]	CONIGLIARO A, FONTANA S, RAIMONDO S, et al. Exosomes: nanocarriers of biological messages[J]. Adv Exp Med Biol, 2017, 998: 23-43. doi: 10.1007/978-981-10-4397-0_2 pmid: 28936730
[28]	WANG S S, GAO X L, LIU X, et al. CD133⁺ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation[J]. Oncotarget, 2016, 7(20): 29051-29062. doi: 10.18632/oncotarget.8665
[29]	CHEN W Q, ALLEN S G, QIAN W Y, et al. Biophysical phenotyping and modulation of ALDH + inflammatory breast cancer stem-like cells[J]. Small, 2019, 15(5): e1802891.
[30]	JIANG Y, SONG Y F, WANG R, et al. NFAT1-mediated regulation of NDEL1 promotes growth and invasion of glioma stem-like cells[J]. Cancer Res, 2019, 79(10): 2593-2603. doi: 10.1158/0008-5472.CAN-18-3297 pmid: 30940662
[31]	CHAI Y, WU H T, LIANG C D, et al. Exosomal lncRNA ROR1-AS1 derived from tumor cells promotes glioma progression via regulating miR-4686[J]. Int J Nanomedicine, 2020, 15: 8863-8872. doi: 10.2147/IJN.S271795
[32]	YOUSEFI H, MAHERONNAGHSH M, MOLAEI F, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance[J]. Oncogene, 2020, 39(5): 953-974. doi: 10.1038/s41388-019-1040-y pmid: 31601996
[33]	JIANG J X, LU J, WANG X L, et al. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling[J]. Aging (Albany NY), 2021, 13(15): 19243-19259.
[34]	CONIGLIARO A, COSTA V, LO DICO A, et al. CD90⁺ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA[J]. Mol Cancer, 2015, 14: 155. doi: 10.1186/s12943-015-0426-x
[35]	SUN Z, WANG L, ZHOU Y L, et al. Glioblastoma stem cell-derived exosomes enhance stemness and tumorigenicity of glioma cells by transferring Notch1 protein[J]. Cell Mol Neurobiol, 2020, 40(5): 767-784. doi: 10.1007/s10571-019-00771-8 pmid: 31853695